Bringing more than 40 years of experience in the medical device industry, this expert witness focuses on product development, regulatory compliance, and commercialization of complex medical technologies, with particular emphasis on radiation therapy and advanced treatment systems. Their litigation-related work includes providing expert witness services and consultation in matters involving medical device design, regulatory requirements, and industry practices. Their expertise spans product definition, market strategy, customer requirements development, competitive analysis, and intellectual property strategy, supporting both early-stage innovation and large-scale technology deployment.

Their technical and commercial background includes leadership in the development and launch of advanced radiation therapy solutions, including particle therapy systems requiring integration of engineering, regulatory, and financial components. This work has involved structuring and supporting large-scale capital projects valued in the hundreds of millions of dollars, developing global pipelines of projects across multiple regions, and creating comprehensive market entry strategies. Their experience also includes evaluation of global supply chains, coordination of multidisciplinary engineering and scientific teams, and development of financial models and external financing structures to support adoption of complex medical infrastructure by healthcare institutions.

A distinguishing aspect of their career is demonstrated impact in executive leadership and operational performance within FDA-regulated environments. This includes building and scaling technical and commercial teams from early-stage groups to large multidisciplinary organizations, driving substantial revenue growth through product launches and market expansion, and leading turnaround efforts under regulatory constraints, including situations involving FDA compliance actions. Their work has also included regulatory innovation, such as supporting alternative FDA commercialization approaches, developing product labeling and reimbursement strategies involving CMS and private payers, and guiding organizations through compliance, quality, and market re-entry challenges. Their leadership contributions have been further recognized through quality and performance achievements, including participation in initiatives associated with industry-recognized excellence awards.

In addition to executive leadership, this expert has contributed to the broader medical technology landscape through involvement in large-scale imaging and information system initiatives and collaboration with healthcare executives on adoption of advanced technologies. Their professional affiliations include leadership roles within the Institute of Electrical and Electronics Engineers (IEEE) Consultant’s Network, as well as membership in organizations such as the American Society for Radiation Oncology (ASTRO), the European Society for Radiotherapy and Oncology (ESTRO), and the Particle Therapy Co-Operative Group (PTCOG). They hold a Master of Business Administration in marketing and finance and a Bachelor of Science degree in electrical engineering, supporting a career that integrates technical expertise, regulatory knowledge, and executive-level strategy in complex medical device environments.